1. Home
  2. ERNA vs LUCY Comparison

ERNA vs LUCY Comparison

Compare ERNA & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eterna Therapeutics Inc.

ERNA

Eterna Therapeutics Inc.

HOLD

Current Price

$7.66

Market Cap

5.8M

Sector

Health Care

ML Signal

HOLD

Logo Innovative Eyewear Inc.

LUCY

Innovative Eyewear Inc.

HOLD

Current Price

$1.07

Market Cap

5.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERNA
LUCY
Founded
2018
2017
Country
United States
United States
Employees
N/A
11
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
5.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ERNA
LUCY
Price
$7.66
$1.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5M
84.3K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
31.29
N/A
EPS
N/A
N/A
Revenue
$582,000.00
N/A
Revenue This Year
N/A
$175.92
Revenue Next Year
N/A
$205.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.13
$0.95
52 Week High
$7.70
$3.54

Technical Indicators

Market Signals
Indicator
ERNA
LUCY
Relative Strength Index (RSI) 98.80 49.44
Support Level $0.23 $1.00
Resistance Level N/A $1.19
Average True Range (ATR) 0.44 0.04
MACD 0.79 0.00
Stochastic Oscillator 97.24 59.96

Price Performance

Historical Comparison
ERNA
LUCY

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the intrinsic tumor-homing ability of MSCs (mesenchymal stem cells) to slip through the tumor's defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment. The firm's initial focus is to develop ERNA-101 in platinum-resistant ovarian cancer. Through another product candidate, ERNA-201, it is investigating anti-inflammatory cytokine (IL-10) secreting iMSCs in autoimmune disorders like rheumatoid arthritis. The company operates in a single reportable segment, the research and development of cellular therapies.

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.

Share on Social Networks: